Emerging nerve fibre bundles from SD-OCT

Article

The future of glaucoma diagnosis and management

Thus, in a collaborative effort at The University of Iowa (also including glaucoma specialist Dr Young Kwon, retinal specialist and engineer Dr Michael Abràmoff, and engineers Dr Milan Sonka, Dr Kyungmoo Lee and Dr Meindert Niemeijer), we have recently been examining the use of nerve bundle patterns from SD-OCT. As a first step in this direction, we have demonstrated that a colourcoded correlation map resembling expected nerve fibre bundle patterns emerges through a structure–structure correlative analysis of the GCL and RNFL from SDOCT across subjects.1 The work, published in Investigative Ophthalmology & Visual Science,1 first involves using our three-dimensional image analysis methodology to obtain regional thickness measurements of the GCL in 66 macular locations and regional thickness measurements of the RNFL in 12 peripapillary wedge locations from each subject. Then, the resulting colour-coded correlation map is obtained by colour-coding each macular GCL region with the most correlative peripapillary wedge region.

Using 3D image analysis to obtain regional GCL and RNFL thickness measurements

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.